Wij zijn onze website aan het vernieuwen.

Ontdekt u nog een pagina die niet klopt of hebt u een goede suggestie, laat het ons dan weten via webmedia@umcutrecht.nl.

Deze website maakt gebruik van cookies

Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Lees meer over het cookiebeleid.

prof. dr. A.L. (A.L.) Bredenoord Full Professor

  • Department of Public Health, Healthcare Innovation & Evaluation and Medical Humanities (PHM)
  • Julius Center Research Program Methodology

A.L. Bredenoord

Contact

Research Programs

Biography

Prof dr Annelien Bredenoord is a professor of Ethics of Biomedical Innovation at the University Medical Center Utrecht. Her research, consultancy and teaching is focused on the ethical issues in emerging biomedical technology and translational medicine.

She is particularly fascinated by the rapid developments in genetics/genomics, regenerative medicine, stem cell research, biobanking, surgical innovation, Big Data and the associated ethical and societal challenges: how to translate biomedical innovations from basic research into clinical care and society in an ethically sound way?

She published widely in those fields and is member of several (inter)national committees among which the Ethics Committee of the International Society for Stem Cell Research (ISSCR), The Young Academy of the Royal Netherlands Academy of Arts and Sciences (KNAW), The Young Health Council, The National Indication Committee Preimplantation Genetic Diagnosis, The NIAS Lorenz Advisory Board, L 'Oreal UNESCO For Women in Science program, and UMC Utrecht’s Research Ethics Committee (METC).

She obtained a VENI grant to study the ethics of translational stem cell research and supervises several PhD-students and medical students. She teaches ethics at the Medical School of Utrecht University.

Annelien has been political active for the Dutch social-liberal party D66 for 15 years. As of 2015, she is member of the Dutch Senate (Eerste Kamer) on behalf of D66.

Side Activities

  • - International Society for Stem Cell Research (ISSCR): Chair of the Ethics Committee (2016 - ongoing)      

    -    International Stem Cell Forum (ISCF): Ethics Working Party (2011 - ongoing)

    -          European Meeting on Psycho-Social Aspects of Genetics (EMPAG): Scientific Board (2014 - ongoing)

    -          NIAS Lorentz Advisory Board (2015 – ongoing)

    -          The Royal Netherlands Academy of Arts and Sciences (KNAW): The Young Academy (De Jonge Akademie) (2014-2019)

    -          Dutch Association for Clinical Genetics: Ethics Committee (2013 – ongoing)

    -          National Indication Committee for Preimplantation Genetic Diagnosis (2012 – ongoing)

    -          Member Research Ethics Committee (METC) UMC Utrecht

    -          Member of UMC Utrecht Ethics Committee on Reproductive Medicine

    -          September 2008: Academic Visitor at the Mitochondrial Research Group, the Medical School, University of Newcastle-upon-Tyne, UK

Fellowship and Awards

  • -          Dutch Cancer Society KWF grant: “An empirical ethics study to introduce next-generation DNA sequencing into cancer care in a responsible way” (2014-2017)

    -          University Medical Center Utrecht Strategic Program Associate Professorship grant (2014)

    -          The Netherlands Organisation for Health Research and Development ZonMw VENI grant: “Ethics of translational stem cell research: moving pluripotent stem cells to the clinic” (2012-2015)

    -          BioMedical Materials Program (BMM): “Regenerative Medicine and early intervention in intervertebral disc disease: ethics from bench to bedside” (2011-2014)

    -          The Netherlands Organisation for Health Research and Development ZonMw Program Priority Medicines for Children: “To store or not to store? A normative analysis of consent in pediatric biobanks” ((2011-2014)

    -          The Netherlands Organisation for Health Research and Development ZonMw Program Ethics & Health Care: “Research ethics in genomics studies: towards a protocol for returning individual genetic data to research participants” (2010-2011)

    -          European Neuromuscular Centre International Workshop: grant to organize an international expert meeting: the 174th ENMC international workshop on Applying Pre-implantation Genetic Diagnosis to mtDNA disease” (Naarden, 19-21 March, 2010)

Research Output (75)

Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer

Bijlsma Rhode, Wouters Roel, Wessels Hester, Sleijfer Stefan, Beerepoot Laurens, Ten Bokkel Huinink Daan, Cruijsen Hester, Heijns Joan, Lolkema Martijn P, Steeghs Neeltje, van Voorthuizen Theo, Vulink Annelie, Witteveen Els, Ausems Margreet, Bredenoord Annelien, May Anne M, Voest Emile apr 2020, In: ESMO open. 5 9 p.

What constitutes a reasonable compensation for non-commercial oocyte donors:an analogy with living organ donation and medical research participation

Kool Emy, van der Graaf Rieke, Bos Annelies, Fauser Bartholomeus, Bredenoord Annelien 1 nov 2019, In: Journal of Medical Ethics. 45 , p. 736-741 6 p.

Passive data collection and use in healthcare:A systematic review of ethical issues

Maher Nicole A., Senders Joeky T., Hulsbergen Alexander F.C., Lamba Nayan, Parker Michael, Onnela Jukka Pekka, Bredenoord Annelien L., Smith Timothy R., Broekman Marike L.D. 1 sep 2019, In: International Journal of Medical Informatics. 129 , p. 242-247 6 p.

If it ain't broke don't fix it? Ethics of splinting deformed newborn ears

van Wijk M. P., Wouters R. H.P., Bredenoord A. L., Kon M., Breugem C. C. 1 aug 2019, In: Journal of Plastic, Reconstructive and Aesthetic Surgery. 72 , p. 1396-1402 7 p.

Unconsented genetic testing in psychiatry:an (almost) no go?

Luykx Jurjen J., van der Spek Rick, van Veen Sisco, Lo-A-Foe Wonnie, Giesbertz Noor A.A., Bredenoord Annelien L., Palmboom Ger G. 1 aug 2019, In: The Lancet Psychiatry. 6 , p. 641-642 2 p.

Understanding (in) Consent for Governance

Lensink MA, Boers SN, Jongsma KR, Bredenoord AL 8 mei 2019, In: The American Journal of Bioethics. 19 , p. 43-45 3 p.

A duty to recontact in genetics:context matters

Giesbertz Noor A.A., van Harten Wim H., Bredenoord Annelien L. 1 apr 2019, In: Nature Reviews. Genetics. 20 , p. 371-372 2 p.

Stakeholders views on the ethical aspects of oocyte banking for third-party assisted reproduction:a qualitative interview study with donors, recipients and professionals

Kool E M, van der Graaf R, Bos A M E, Pieters J J P M, Custers I M, Fauser B C J M, Bredenoord A L 30 mrt 2019, In: Human Reproduction. 34 , p. 842-850 9 p.

The ethics of genome editing in non-human animals:A systematic review of reasons reported in the academic literature

de Graeff N, Jongsma Karin, Johnston Josephine, Hartley Sarah, Bredenoord AL 25 mrt 2019, In: Philosophical transactions / Royal Society of London. Biological sciences. 374 , p. 1-25 25 p.

A Human(e) Factor in Clinical Decision Support Systems

Bezemer Tim, De Groot Mark C.H., Blasse Enja, Ten Berg Maarten J., Kappen Teus H., Bredenoord Annelien L., Van Solinge Wouter W., Hoefer Imo E., Haitjema Saskia 19 mrt 2019, In: Journal of Medical Internet Research. 21

All Research Output (75)
To top